88 related articles for article (PubMed ID: 8093045)
1. Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: characterization of the human E-cadherin gene promoter.
Bussemakers MJ; Giroldi LA; van Bokhoven A; Schalken JA
Biochem Biophys Res Commun; 1994 Sep; 203(2):1284-90. PubMed ID: 8093045
[TBL] [Abstract][Full Text] [Related]
2. The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element.
Behrens J; Löwrick O; Klein-Hitpass L; Birchmeier W
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11495-9. PubMed ID: 1763063
[TBL] [Abstract][Full Text] [Related]
3. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
Hennig G; Behrens J; Truss M; Frisch S; Reichmann E; Birchmeier W
Oncogene; 1995 Aug; 11(3):475-84. PubMed ID: 7630631
[TBL] [Abstract][Full Text] [Related]
4. P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer.
Jarrard DF; Paul R; van Bokhoven A; Nguyen SH; Bova GS; Wheelock MJ; Johnson KR; Schalken J; Bussemakers M; Isaacs WB
Clin Cancer Res; 1997 Nov; 3(11):2121-8. PubMed ID: 9815605
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the regulatory regions in the human desmoglein genes encoding the pemphigus foliaceous and pemphigus vulgaris antigens.
Adams MJ; Reichel MB; King IA; Marsden MD; Greenwood MD; Thirlwell H; Arnemann J; Buxton RS; Ali RR
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):165-74. PubMed ID: 9405290
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
[TBL] [Abstract][Full Text] [Related]
7. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.
Tamura G; Yin J; Wang S; Fleisher AS; Zou T; Abraham JM; Kong D; Smolinski KN; Wilson KT; James SP; Silverberg SG; Nishizuka S; Terashima M; Motoyama T; Meltzer SJ
J Natl Cancer Inst; 2000 Apr; 92(7):569-73. PubMed ID: 10749913
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Graff JR; Herman JG; Lapidus RG; Chopra H; Xu R; Jarrard DF; Isaacs WB; Pitha PM; Davidson NE; Baylin SB
Cancer Res; 1995 Nov; 55(22):5195-9. PubMed ID: 7585573
[TBL] [Abstract][Full Text] [Related]
9. Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer.
Li LC; Zhao H; Nakajima K; Oh BR; Ribeiro Filho LA; Carroll P; Dahiya R
J Urol; 2001 Aug; 166(2):705-9. PubMed ID: 11458121
[TBL] [Abstract][Full Text] [Related]
10. Role of E boxes in the repression of E-cadherin expression.
Giroldi LA; Bringuier PP; de Weijert M; Jansen C; van Bokhoven A; Schalken JA
Biochem Biophys Res Commun; 1997 Dec; 241(2):453-8. PubMed ID: 9425291
[TBL] [Abstract][Full Text] [Related]
11. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas.
Yoshiura K; Kanai Y; Ochiai A; Shimoyama Y; Sugimura T; Hirohashi S
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7416-9. PubMed ID: 7543680
[TBL] [Abstract][Full Text] [Related]
12. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells.
Morton RA; Ewing CM; Nagafuchi A; Tsukita S; Isaacs WB
Cancer Res; 1993 Aug; 53(15):3585-90. PubMed ID: 8339265
[TBL] [Abstract][Full Text] [Related]
13. Ksp-cadherin gene promoter. I. Characterization and renal epithelial cell-specific activity.
Whyte DA; Li C; Thomson RB; Nix SL; Zanjani R; Karp SL; Aronson PS; Igarashi P
Am J Physiol; 1999 Oct; 277(4):F587-98. PubMed ID: 10516284
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells.
Tryndyak VP; Beland FA; Pogribny IP
Int J Cancer; 2010 Jun; 126(11):2575-83. PubMed ID: 19839049
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of E-cadherin by promoter hypermethylation in oral carcinoma cells.
Maeda G; Chiba T; Aoba T; Imai K
Odontology; 2007 Jul; 95(1):24-9. PubMed ID: 17660978
[TBL] [Abstract][Full Text] [Related]
16. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin.
Wong AS; Gumbiner BM
J Cell Biol; 2003 Jun; 161(6):1191-203. PubMed ID: 12810698
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors.
Bolós V; Peinado H; Pérez-Moreno MA; Fraga MF; Esteller M; Cano A
J Cell Sci; 2003 Feb; 116(Pt 3):499-511. PubMed ID: 12508111
[TBL] [Abstract][Full Text] [Related]
18. N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1.
Alexander NR; Tran NL; Rekapally H; Summers CE; Glackin C; Heimark RL
Cancer Res; 2006 Apr; 66(7):3365-9. PubMed ID: 16585154
[TBL] [Abstract][Full Text] [Related]
19. Liver-intestine cadherin: molecular cloning and characterization of a novel Ca(2+)-dependent cell adhesion molecule expressed in liver and intestine.
Berndorff D; Gessner R; Kreft B; Schnoy N; Lajous-Petter AM; Loch N; Reutter W; Hortsch M; Tauber R
J Cell Biol; 1994 Jun; 125(6):1353-69. PubMed ID: 8207063
[TBL] [Abstract][Full Text] [Related]
20. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
